JW Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50,673
| Closed | -$5.21M | – | 17 |
|
|
2023
Q2 | $5.21M | Hold |
50,673
| – | – | 1.9% | 6 |
|
|
2023
Q1 | $5.53M | Hold |
50,673
| – | – | 2.12% | 6 |
|
|
2022
Q4 | $5.77M | Hold |
50,673
| – | – | 2.37% | 5 |
|
|
2022
Q3 | $3.14M | Hold |
50,673
| – | – | 1.61% | 5 |
|
|
2022
Q2 | $4.04M | Hold |
50,673
| – | – | 2.15% | 3 |
|
|
2022
Q1 | $5.33M | Hold |
50,673
| – | – | 1.78% | 5 |
|
|
2021
Q4 | $5.46M | Hold |
50,673
| – | – | 1.81% | 3 |
|
|
2021
Q3 | $5.55M | Hold |
50,673
| – | – | 1.67% | 4 |
|
|
2021
Q2 | $4.75M | Hold |
50,673
| – | – | 1.11% | 4 |
|
|
2021
Q1 | $4.66M | Hold |
50,673
| – | – | 1.34% | 4 |
|
|
2020
Q4 | $3.71M | Hold |
50,673
| – | – | 1.52% | 4 |
|
|
2020
Q3 | $3.94M | Hold |
50,673
| – | – | 2.27% | 5 |
|
|
2020
Q2 | $2.82M | Hold |
50,673
| – | – | 1.87% | 5 |
|
|
2020
Q1 | $1.5M | Sell |
50,673
-50,300
| -50% | -$1.7M | 1.38% | 7 |
|
|
2019
Q4 | $3.65M | Sell |
100,973
-169,802
| -63% | -$5.21M | 2.63% | 5 |
|
|
2019
Q3 | $7.37M | Hold |
270,775
| – | – | 6.49% | 3 |
|
|
2019
Q2 | $6.51M | Hold |
270,775
| – | – | 3.5% | 5 |
|
|
2019
Q1 | $7.16M | Hold |
270,775
| – | – | 3.67% | 7 |
|
|
2018
Q4 | $5.29M | Hold |
270,775
| – | – | 3.9% | 6 |
|
|
2018
Q3 | $5.3M | Hold |
270,775
| – | – | 2.86% | 7 |
|
|
2018
Q2 | $4.48M | Hold |
270,775
| – | – | 2.86% | 7 |
|
|
2018
Q1 | $3.85M | Hold |
270,775
| – | – | 3.79% | 7 |
|
|
2017
Q4 | $3.95M | Hold |
270,775
| – | – | 4.21% | 4 |
|
|
2017
Q3 | $3.43M | Hold |
270,775
| – | – | 2.51% | 10 |
|
|
2017
Q2 | $3.21M | Sell |
270,775
-236,300
| -47% | -$2.94M | 2.05% | 11 |
|
|
2017
Q1 | $7.5M | Hold |
507,075
| – | – | 1.56% | 7 |
|
|
2016
Q4 | $8.21M | Hold |
507,075
| – | – | 5.46% | 6 |
|
|
2016
Q3 | $9.19M | Sell |
507,075
-122,000
| -19% | -$2.38M | 6.33% | 5 |
|
|
2016
Q2 | $10.4M | Sell |
629,075
-44,000
| -7% | -$712K | 8.24% | 4 |
|
|
2016
Q1 | $11.2M | Hold |
673,075
| – | – | 7.28% | 5 |
|
|
2015
Q4 | $14.6M | Sell |
673,075
-100,824
| -13% | -$1.96M | 5.44% | 4 |
|
|
2015
Q3 | $15.3M | Buy |
773,899
+7,175
| +0.9% | +$227K | 5.56% | 5 |
|
|
2015
Q2 | $26.6M | Buy |
766,724
+37,115
| +5% | +$1.13M | 8.1% | 3 |
|
|
2015
Q1 | $18.9M | Buy |
729,609
+148,925
| +26% | +$2.73M | 8.19% | 4 |
|
|
2014
Q4 | $7.49M | Buy |
+580,684
| New | +$7.27M | 5.62% | 8 |
|
Other funds holding HZNP
PCM
HI
UOC
ACA
FCM
JW Asset Management's HZNP Position: Q3 2023 in Review
JW Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 50,673 shares — an estimated $5.21M sold.
JW Asset Management first reported a position in HZNP in Q4 2014 and held it in 35 quarters. The position peaked at $26.6M in Q2 2015. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.
- JW Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
- JW Asset Management sold 50,673 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $5.21M.
- JW Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 35 quarters.
- JW Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $26.6M in Q2 2015.
- 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.
Based on JW Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.